Index of reports
> Disability (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cerubidine (Daunorubicin) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cerubidine side effects in 21 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-30
Patient: 21 year old male, weighing 82.6 kg (181.7 pounds)
Reactions: Toxic Optic Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: unk
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-27
Valacyclovir Hydrochloride
Dosage: 1 g, 1x/day
Administration route: Oral
Start date: 2011-10-13
End date: 2011-12-07
Cerubidine
Dosage: 60 mg, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Vfend
Dosage: unk
Start date: 2011-10-17
End date: 2011-12-07
Phenoxymethyl Penicillin
Dosage: 3 millioniu, 1x/day
Administration route: Oral
Start date: 2011-11-18
End date: 2011-12-07
Vincristine
Dosage: 2 mg, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Nexium
Dosage: unk
Administration route: Oral
Start date: 2011-10-17
End date: 2011-11-11
Nexium
Dosage: unk
Administration route: Oral
Start date: 2011-11-15
End date: 2011-12-07
Kidrolase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-24
End date: 2011-11-16
Other drugs received by patient: Methotrexate; Cyclophosphamide; Cytarabine
Possible Cerubidine side effects in male
Reported by a physician from France on 2012-05-25
Patient: male
Reactions: Toxic Optic Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Vincristine
Dosage: 2mg cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Phenoxymethyl Penicillin
Dosage: 3iu6 per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-18
End date: 2011-12-07
Nexium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-17
End date: 2011-12-07
Vfend
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-17
End date: 2011-12-07
Dexamethasone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-20
End date: 2011-10-27
Valacyclovir Hydrochloride
Dosage: 1g per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-13
End date: 2011-12-07
Kidrolase
Dosage: 10iu3 cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-10-24
End date: 2011-11-16
Cerubidine
Dosage: 60mg cyclic
Indication: T-Cell Type Acute Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Other drugs received by patient: Methotrexate; Cyclophosphamide; Cytarabine
Possible Cerubidine side effects in 21 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-24
Patient: 21 year old male, weighing 82.6 kg (181.7 pounds)
Reactions: Toxic Optic Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Vfend
Dosage: unk
Start date: 2011-10-17
End date: 2011-12-07
Nexium
Dosage: unk
Administration route: Oral
Start date: 2011-11-15
End date: 2011-12-07
Valacyclovir Hydrochloride
Dosage: 1 g, 1x/day
Administration route: Oral
Start date: 2011-10-13
End date: 2011-12-07
Dexamethasone
Dosage: unk
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-27
Cerubidine
Dosage: 60 mg, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Phenoxymethyl Penicillin
Dosage: 3 millioniu, 1x/day
Administration route: Oral
Start date: 2011-11-18
End date: 2011-12-07
Vincristine
Dosage: 2 mg, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-20
End date: 2011-11-10
Nexium
Dosage: unk
Administration route: Oral
Start date: 2011-10-17
End date: 2011-11-11
Kidrolase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-10-24
End date: 2011-11-16
Other drugs received by patient: Cyclophosphamide; Cytarabine; Methotrexate
Possible Cerubidine side effects in male
Reported by a physician from France on 2012-05-23
Patient: male
Reactions: Toxic Optic Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg per course
Start date: 2011-10-27
Cerubidine
Dosage: 60 mg per course
Start date: 2011-10-20
Kidrolase
Start date: 2011-10-24
Vfend
Start date: 2011-10-17
End date: 2011-11-27
Valacyclovir Hydrochloride
Administration route: Oral
Start date: 2011-10-13
End date: 2011-12-07
Vincristine
Dosage: 2 mg per course
Start date: 2011-11-10
Cerubidine
Dosage: 60 mg per course
Start date: 2011-11-10
Vfend
Start date: 2011-11-28
End date: 2011-12-05
Dexamethasone
Dosage: daily
Administration route: Oral
Start date: 2011-10-20
End date: 2011-11-27
Phenoxymethyl Penicillin
Dosage: 3 000 000 iu
Administration route: Oral
Start date: 2011-11-18
End date: 2011-12-07
Kidrolase
Start date: 2011-10-27
Kidrolase
Start date: 2011-11-16
Cerubidine
Dosage: 60 mg per course
Start date: 2011-11-03
Nexium
Dosage: daily
Administration route: Oral
Start date: 2011-10-17
End date: 2011-11-11
Vincristine
Dosage: 2 mg per course
Start date: 2011-11-03
Kidrolase
Start date: 2011-11-10
Kidrolase
Start date: 2011-11-13
Kidrolase
Start date: 2011-11-06
Nexium
Administration route: Oral
Start date: 2011-11-15
End date: 2011-12-07
Vfend
Start date: 2011-12-06
End date: 2011-12-07
Vincristine
Dosage: 2 mg per course
Start date: 2011-10-20
Kidrolase
Start date: 2011-10-30
Kidrolase
Start date: 2011-11-03
Cerubidine
Dosage: 60 mg per course
Start date: 2011-10-27
|